#Class Action #Pomerantz LLP #Park Ha Biological Technology

Investor Alert: Class Action Lawsuit Filed Against Park Ha Biological Technology

The renowned Pomerantz Law Firm has announced the initiation of a class action lawsuit against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH), drawing attention to significant allegations of securities fraud tied to the company. This legal action serves as a critical reminder for investors who have suffered losses related to their investments in Park Ha during its Class Period.

Background of the Case

The lawsuit emerged amid claims that Park Ha, along with certain corporate officers and directors, engaged in illegal business practices, specifically securities fraud. Investors are advised of upcoming deadlines for participation in this legal action; they can contact Pomerantz for more details.

The lawsuit covers the period when Park Ha’s stock price fluctuated wildly, particularly between its initial public offering (IPO) price of $4.00 and a staggering peak of $41.49 on July 7, 2025. This growth occurred despite a conspicuous absence of substantiated corporate developments that would justify such a price surge.

Allegations of Fraud and Market Manipulation

The complaint indicates that Park Ha’s rise was fleeting and propped up by suspected fraudulent activity. Reports suggest that the company was the victim of a deceptive